Early Antibiotic Use Alters Long-Term Lung Immunity in Babies, Study Finds

Antibiotics Save Lives but Leave Lasting Immune System Changes

Antibiotics are a critical tool in saving the lives of newborns, but new research reveals they may also leave a lasting mark on babies’ immune systems. Scientists at the University of Rochester Medicine found that early antibiotic exposure disrupts the natural balance of gut bacteria in infants, which then "travels" to the lungs. This disruption fundamentally rewires how lung immune cells are programmed, shifting their function from aggressive infection-fighting to damage control and repair.

Study Details and Key Findings

The research, published in Mucosal Immunology, examined how antibiotic-driven changes in gut bacteria altered lung immune cells in newborn mice. These changes persisted into young adulthood, suggesting that early-life antibiotic exposure may have long-term consequences for respiratory health.

In the study, scientists mapped lung immune cells in newborn mice and compared them to adult mice. When antibiotics were administered to newborn mice—similar to treatments in neonatal intensive care units (NICUs)—it altered the function of immune cells. Key gut bacteria depletion led to:

• Overactivation of genes that control lung responses to infection
• Suppression of signals that prime cells to kill viruses
• Increased signals that prioritize tissue repair, typically seen in adults

These changes were not observed in mice with healthy, undisturbed gut microbiomes. The most striking finding was that the alterations did not fade over time. Mice that received antibiotics early in life still showed significant differences in their lung immune cells in young adulthood, indicating that these shifts persisted through development.

Expert Insights and Clinical Implications

Hitesh Deshmukh, senior study author and chief of neonatology at University of Rochester Medicine Golisano Children’s Hospital, emphasized the importance of antibiotics while highlighting the need for caution:

"The research in no way suggests doctors should hesitate to use antibiotics in babies when necessary, as they are one of the most important tools in preventing serious illness and even death. But we’re learning more about how disrupting babies’ gut bacteria in early life can change immune cells in ways that persist long after infancy."

Antibiotics are commonly used in NICUs and newborn nurseries, where doctors balance their benefits against risks. While antibiotics reduce infections, they also eliminate harmful and beneficial bacteria, increasing the risk of gastrointestinal infections like diarrhea and long-term conditions such as asthma and allergies.

Uday Pandey, postdoctoral researcher and study author, added:

"We hope these findings will ultimately guide new approaches, whether that means protecting the microbiome during antibiotic treatment or developing targeted therapies to support babies whose early immune programming may have been altered."

Why Early-Life Gut Bacteria Matters

Deshmukh noted that the gut microbiota in babies is still evolving, making early changes more likely to be amplified over time:

"In babies, the gut microbiota is evolving, so any small changes that happen early on are more likely to get propagated and amplified as time passes."

The research team is now exploring ways to mitigate these effects, including protecting the microbiome during antibiotic treatment or developing therapies to support altered immune programming in infants.

Future Directions and Research

The study builds on a large biorepository of donated lung tissue at URochester Medicine Golisano Children’s Hospital, which may provide further insights into the long-term effects of early antibiotic exposure on human health.